IF by specialty › Oncology
Clinical Cancer Research — Impact Factor
The 2025 Impact Factor of Clinical Cancer Research is 10.9 (Q1 in Oncology; subscription or hybrid).
- Impact Factor
- 10.9 JCR 2025
- JCR category
- Oncology
- Quartile
- Q1 in Oncology
- Publisher
- AACR
- Open access
- subscription or hybrid
- Abbreviations
- CCR, Clin Cancer Res
- IF source
- bioxbio.com
Position within the field
Ranked 15 of the 42 journals in Oncology on this site (top 50%).
Oncology journals with a similar Impact Factor
- Journal for ImmunoTherapy of Cancer IF 11.7
- Cancer Treatment Reviews IF 10.6
- ESMO Open IF 10.6
- European Journal of Cancer IF 7.9
- British Journal of Cancer IF 7.8
- Journal of the National Cancer Institute IF 7.7
About this value
Clinical Cancer Research is abbreviated CCR / Clin Cancer Res. The Journal Impact Factor of Clinical Cancer Research (JCR 2025, released June 2026) is 10.9. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.